Uniphos Enterprises Ltd Stock Price Today (NSE: UNIENTER)
Fundamental Score
Uniphos Enterprises Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Uniphos Enterprises Ltd share price today is ₹106.08, up +0.90% on NSE/BSE as of 1 June 2026. Uniphos Enterprises Ltd (UNIENTER) is a Small-cap company in the Trading - Chemicals sector with a market capitalisation of ₹976.12 (Cr). The 52-week high for UNIENTER share price is ₹168.50 and the 52-week low is ₹87.51. At a P/E ratio of 51.43x, UNIENTER is currently trading below its industry average P/E of 65.53x. The company has a Return on Equity (ROE) of 0.01% and a debt-to-equity ratio of 0.00.
Uniphos Enterprises Ltd Share Price Chart — NSE/BSE Historical Performance
Uniphos Enterprises Ltd share price chart: -1.51% return over the past month. 52-week high ₹168.50, 52-week low ₹87.51.
Uniphos Enterprises Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹107.06 | ₹109.98 | ₹105.10 | ₹106.52 | 5.17K (Cr) | |
| ₹109.75 | ₹109.75 | ₹107.00 | ₹107.36 | 2.31K (Cr) | |
| ₹111.88 | ₹111.88 | ₹105.36 | ₹107.52 | 8.66K (Cr) | |
| ₹106.11 | ₹111.35 | ₹104.25 | ₹108.25 | 14.74K (Cr) | |
| ₹109.99 | ₹109.99 | ₹105.52 | ₹106.64 | 13.89K (Cr) | |
| ₹111.70 | ₹122.99 | ₹106.00 | ₹108.56 | 1.85L (Cr) | |
| ₹105.60 | ₹105.70 | ₹102.39 | ₹104.82 | 1.93K (Cr) | |
| ₹103.94 | ₹106.99 | ₹102.25 | ₹102.39 | 2.45K (Cr) | |
| ₹104.00 | ₹106.65 | ₹101.70 | ₹103.94 | 2.67K (Cr) | |
| ₹111.99 | ₹111.99 | ₹102.00 | ₹102.47 | 3.65K (Cr) |
Uniphos Enterprises Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹107.30 | ₹122.99 | ₹101.50 | ₹106.52 | -0.73% | |
| ₹97.69 | ₹114.50 | ₹90.00 | ₹107.30 | +9.84% | |
| ₹106.97 | ₹107.95 | ₹87.51 | ₹91.19 | -14.75% | |
| ₹121.09 | ₹126.83 | ₹100.00 | ₹107.22 | -11.45% | |
| ₹144.60 | ₹151.99 | ₹112.30 | ₹114.93 | -20.52% | |
| ₹145.01 | ₹148.42 | ₹132.15 | ₹143.63 | -0.95% | |
| ₹145.25 | ₹158.00 | ₹142.10 | ₹145.14 | -0.08% | |
| ₹149.82 | ₹153.99 | ₹143.15 | ₹148.21 | -1.07% | |
| ₹148.65 | ₹161.80 | ₹146.50 | ₹149.82 | +0.79% | |
| ₹161.50 | ₹161.99 | ₹149.21 | ₹152.15 | -5.79% | |
| ₹152.79 | ₹168.50 | ₹150.02 | ₹160.20 | +4.85% | |
| ₹156.15 | ₹167.89 | ₹146.41 | ₹152.94 | -2.06% |
AI Research Briefing
Powered by Gemini · 2026-04-04
High sales growth is overshadowed by poor profitability and negative cash flow in this small-cap chemical trading firm.
Uniphos Enterprises Ltd (UNIENTER) - Trading Chemicals **Macro backdrop
- Potential undervaluation based on P/E ratio
- High sales growth
- Low debt
- Consistent profitability in coming quarters
- Improved free cash flow generation
- Positive news flow regarding contracts or expansions
- Negative free cash flow
- Poor ROE and ROCE
- Negative profit CAGR
Promoter holding is high (73.79%) and stable, with increasing FII interest (15.71%). DII interest is nil.
Chemical trading sector faces mixed signals with fluctuating raw material prices and varying demand.
No major company-specific news in the last 3 weeks
Poor. Negative free cash flow over the last 5 years.
Monitor for improved profitability and cash flow generation over the next 3-6 months.
Primary Thesis Risk
Inability to convert sales growth into sustainable profits and positive cash flow.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Uniphos Enterprises Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Uniphos Enterprises Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of UNIENTER across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Attractive Valuation (P/E: 51.43 vs Industry: 65.53)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (500.00%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (244.44% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (17.18x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (73.79%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (0.01%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (0.06%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-9.65%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-57.73% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-57.73% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-11.73 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Uniphos Enterprises Ltd vs Trading - Chemicals Peers
Peer Comparison - Trading - Chemicals
Compare Uniphos Enterprises Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Uniphos Enterprises LtdUniphos Enterpr...Selected✓ UNIENTER • 500429 | 36.1/100 | ₹106.08₹106 | ₹976.12₹976.12 | 51.43Average 51.4 Average | 0.01%Poor 0.01% Poor | 0.06%Poor 0.06% Poor | 0.00Excellent 0.0 Excellent | -57.73%Poor -57.73% Poor | 244.44%Excellent 244.44% Excellent | 0.35% |
A 1A 1... AIL • 542012 | 25.9/100 | ₹44.10₹44 | ₹3077.11₹3077.11 | 1225.94Average 1225.9 Average | 7.82%Poor 7.82% Poor | 10.63%Average 10.63% Average | 0.35Excellent 0.3 Excellent | 3.75%Average 3.75% Average | 23.45%Excellent 23.45% Excellent | 0.06% |
Vinyl Chemicals India LtdVinyl Chemicals... VINYLINDIA • 524129 | 59.6/100 | ₹264.10₹264 | ₹451.64₹451.64 | 23.03Average 23.0 Average | 15.57%Good 15.57% Good | 21.12%Excellent 21.12% Excellent | 0.00Excellent 0.0 Excellent | 24.13%Excellent 24.13% Excellent | 10.92%Good 10.92% Good | 2.82% |
59.8/100 | ₹40.86₹41 | ₹430.15₹430.15 | 35.88Average 35.9 Average | 10.94%Average 10.94% Average | 14.08%Average 14.08% Average | 0.15Excellent 0.1 Excellent | 33.46%Excellent 33.46% Excellent | 24.82%Excellent 24.82% Excellent | 0.07% | |
Shiv Texchem LtdShiv Texchem Lt... SHIVTEXCHEM • 544272 | 42.5/100 | ₹156.05₹156 | ₹405.51₹405.51 | 5.76Average 5.8 Average | 18.30%Good 18.30% Good | 14.46%Average 14.46% Average | 1.15Average 1.1 Average | — — | — — | 0.00% |
Evexia Lifecare LtdEvexia Lifecare... EVEXIA • 524444 | 0/100 | ₹1.15₹1 | ₹332.28₹332.28 | 232.37Average 232.4 Average | 0.32%Poor 0.32% Poor | 0.30%Poor 0.30% Poor | 2.16Poor 2.2 Poor | -23.15%Poor -23.15% Poor | 1.97%Average 1.97% Average | 0.00% |
27.7/100 | ₹31.15₹31 | ₹315.31₹315.31 | 79.62Average 79.6 Average | 16.42%Good 16.42% Good | 18.53%Good 18.53% Good | 0.37Excellent 0.4 Excellent | — — | — — | 0.00% | |
Yash Chemex LtdYash Chemex Ltd... YASHCHEM • 539939 | 34.7/100 | ₹53.87₹54 | ₹94.46₹94.46 | 53.67Average 53.7 Average | 5.60%Poor 5.60% Poor | 8.13%Poor 8.13% Poor | 0.35Excellent 0.3 Excellent | -2.94%Poor -2.94% Poor | 3.96%Average 3.96% Average | 0.00% |
Mysore Petro Chemicals LtdMysore Petro Ch... MYSORPETRO • 506734 | 35/100 | ₹102.00₹102 | ₹67.88₹67.88 | 8.22Average 8.2 Average | 1.30%Poor 1.30% Poor | 7.82%Poor 7.82% Poor | 0.00Excellent 0.0 Excellent | -8.99%Poor -8.99% Poor | 20.87%Excellent 20.87% Excellent | 1.94% |
Laffans Petrochemicals LtdLaffans Petroch... LAFFANSQ • 524522 | 19.6/100 | ₹27.28₹27 | ₹26.92₹26.92 | — — | 1.69%Poor 1.69% Poor | 2.30%Poor 2.30% Poor | 0.01Excellent 0.0 Excellent | 17.45%Excellent 17.45% Excellent | -7.70%Poor -7.70% Poor | 0.00% |
Citichem India LtdCitichem India ... CITICHEM • 544324 | 54.6/100 | ₹18.00₹18 | ₹17.34₹17.34 | 9.69Average 9.7 Average | 8.91%Poor 8.91% Poor | 11.56%Average 11.56% Average | 0.34Excellent 0.3 Excellent | 43.81%Excellent 43.81% Excellent | -15.65%Poor -15.65% Poor | 0.00% |
Top Trading - Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- A 1 share price3077.11 Cr
- Vinyl Chemicals India Ltd share price451.64 Cr
- Shankar Lal Rampal Dye Chem Ltd share price430.15 Cr
- Shiv Texchem Ltd share price405.51 Cr
- Evexia Lifecare Ltd share price332.28 Cr
Uniphos Enterprises Ltd PE Ratio History
Historical price-to-earnings ratio for UNIENTER — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.04 | ₹143.63 | 3590.8x |
| FY 2024 | ₹5.55 | ₹157.24 | 28.3x |
| FY 2023 | ₹5.64 | ₹158.85 | 28.2x |
| FY 2022 | ₹7.85 | ₹132.20 | 16.8x |
| FY 2021 | ₹3.52 | ₹130.80 | 37.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Uniphos Enterprises Ltd Dividend History
Annual cash dividends paid by UNIENTER — dividend yield 0.35%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2025 | ₹39.64 Cr |
| FY 2024 | ₹45.20 Cr |
| FY 2023 | ₹39.29 Cr |
| FY 2022 | ₹23.65 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Uniphos Enterprises Ltd Quarterly Performance
Latest quarterly metrics for UNIENTER — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-100.00%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
500.00%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
244.44%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-57.73%
Compounded annual net profit growth over 5 years
Uniphos Enterprises Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for UNIENTER — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Uniphos Enterprises Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Uniphos Enterprises Ltd (UNIENTER) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Uniphos Enterprises Ltd
About UNIENTER (Uniphos Enterprises Ltd)
Uniphos Enterprises Ltd is a multifaceted entity operating within the dynamic realm of chemical trading and allied investments. Founded in 1969 and headquartered in Mumbai, India, ...UNIENTER navigates the complexities of the chemical and agro commodity markets with a long-standing presence. The company strategically sources and distributes a diverse portfolio of chemical products catering to a broad spectrum of industrial applications. Beyond its core trading activities, UNIENTER actively engages in financial investments, demonstrating a commitment to diversified growth. This includes strategic placements in securities and mutual funds, reflecting a calculated approach to maximizing shareholder value and capital appreciation. Through its decades of experience, UNIENTER has established itself as a key player in the Indian market, fostering strong relationships with suppliers and customers. As a subsidiary of Nerka Chemicals Private Limited, Uniphos Enterprises Ltd benefits from a synergistic relationship that enhances its market position. This affiliation provides access to resources, expertise, and a broader network within the chemical industry, bolstering UNIENTER's operational capabilities. The company's commitment extends beyond simple transactions, with a focus on building sustainable relationships based on trust and reliability. UNIENTER's operations are characterized by a dedication to quality control, logistical efficiency, and adherence to industry best practices. By understanding the evolving needs of the chemical market, UNIENTER strives to provide timely and effective solutions for its clients. Uniphos Enterprises Ltd's dual focus on chemical trading and strategic investments positions it as a resilient and adaptable player in the Indian business landscape. The company's ability to navigate market fluctuations and leverage opportunities speaks to its robust business model and experienced management team. UNIENTER's long-term vision encompasses sustainable growth, responsible business practices, and a commitment to delivering value to all stakeholders. It continues to evolve, adapting to the changing dynamics of the chemical industry while maintaining its core values of integrity, transparency, and customer focus.
Company Details
Key Leadership
Corporate Events
UNIENTER Share Price: Frequently Asked Questions
What is the current share price of Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd (UNIENTER) trades at ₹106.08 on NSE and BSE. Market cap ₹976.12 (Cr). Educational data only.
What is the P/E ratio of Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd has a P/E of 51.43x vs industry average 65.53x.
What is the Bull Run score for Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd has a Bull Run score of 36.1/100 based on 25+ financial parameters.
Does Uniphos Enterprises Ltd pay dividends?
Uniphos Enterprises Ltd has a dividend yield of 0.35%. Past dividends don't guarantee future payments.
What is the ROE of Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd has ROE of 0.01%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd has debt-to-equity of 0.00.
Is Uniphos Enterprises Ltd a good investment?
Bull Run gives Uniphos Enterprises Ltd a score of 36.1/100. This is not investment advice — consult a SEBI-registered advisor.